Human CD117 / c-kit Protein, His Tag (MALS verified)
分子別名(Synonym)
CD117,SCFR,c-Kit,KIT
表達區(qū)間及表達系統(tǒng)(Source)
Human CD117, His Tag (CD7-H52H4) is expressed from human 293 cells (HEK293). It contains AA Gln 26 - Thr 516 (Accession # P10721-2).
Predicted N-terminus: Gln 26
蛋白結構(Molecular Characterization)

This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 57.1 kDa. The protein migrates as 80-95 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
內毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method / rFC method.
純度(Purity)
>95% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.

背景介紹
肥大/干細胞生長因子受體Kit(c-Kit)作為蛋白激酶超家族、Tyr蛋白激酶家族及CSF-1/PDGF受體亞家族成員,亦稱花斑特性蛋白(PBT)、p145 c-kit、酪氨酸蛋白激酶Kit或CD117。該受體包含五個Ig樣C2型結構域及一個蛋白激酶結構域,是細胞因子KITLG/SCF的細胞表面受體,在細胞存活增殖、造血調控、干細胞維持、配子發(fā)生、肥大細胞發(fā)育遷移與功能、以及黑色素生成中發(fā)揮核心調控作用。結合KITLG/SCF后,CD117可激活多條信號通路,并進一步促進蛋白磷酸酶PTPN6/SHP-1、PTPRU以及轉錄因子STAT1、STAT3、STAT5A和STAT5B的磷酸化。
關鍵字: CD117;CD117蛋白;CD117重組蛋白;ACRO;百普賽斯;
百普賽斯集團ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產業(yè)領域提供關鍵生物試劑產品及解決方案的行業(yè)平臺型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團業(yè)務遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個城市設有辦公室、研發(fā)中心及生產基地。目前累計服務客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關系。集團旗下擁有品牌ACROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學等。